Vanguard Fiduciary Trust »

Miragen Therapeutics shares owned by Vanguard Fiduciary Trust

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Vanguard Fiduciary Trust from 13F filings

Historical chart of Vanguard Fiduciary Trust investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Vanguard Fiduciary Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Vanguard Fiduciary Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 591k 19.56

More positions owned by Vanguard Fiduciary Trust

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Fiduciary Trust

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
State Street Corporation
Bellevue Group
Vanguard Capital Management
Fairmount Funds Management
VR Adviser
Paradigm Biocapital Advisors
Wellington Management Company
Citadel Advisors
Kynam Capital Management
Geode Capital Management
Balyasny Asset Management
Novo A/S

View all funds holding Miragen Therapeutics